| Product Code: ETC9408889 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Neoantigens Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Neoantigens Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Neoantigens Market - Industry Life Cycle |
3.4 South Korea Neoantigens Market - Porter's Five Forces |
3.5 South Korea Neoantigens Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 South Korea Neoantigens Market Revenues & Volume Share, By Therapeutic Specialty, 2021 & 2031F |
3.7 South Korea Neoantigens Market Revenues & Volume Share, By Line of Therapy, 2021 & 2031F |
3.8 South Korea Neoantigens Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 South Korea Neoantigens Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development for personalized medicine |
4.2.2 Growing prevalence of cancer cases in South Korea |
4.2.3 Technological advancements in genomics and bioinformatics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of neoantigen-based therapies |
4.3.2 High cost associated with personalized medicine |
4.3.3 Limited awareness and adoption of neoantigen-based treatments in the healthcare sector |
5 South Korea Neoantigens Market Trends |
6 South Korea Neoantigens Market, By Types |
6.1 South Korea Neoantigens Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 South Korea Neoantigens Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 South Korea Neoantigens Market Revenues & Volume, By Combination Therapy, 2021- 2031F |
6.1.4 South Korea Neoantigens Market Revenues & Volume, By Mono Therapy, 2021- 2031F |
6.2 South Korea Neoantigens Market, By Therapeutic Specialty |
6.2.1 Overview and Analysis |
6.2.2 South Korea Neoantigens Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 South Korea Neoantigens Market Revenues & Volume, By Urinary System Cancer, 2021- 2031F |
6.2.4 South Korea Neoantigens Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.2.5 South Korea Neoantigens Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.6 South Korea Neoantigens Market Revenues & Volume, By Head and Neck Cancer, 2021- 2031F |
6.2.7 South Korea Neoantigens Market Revenues & Volume, By Blood and Bone Marrow Cancer, 2021- 2031F |
6.3 South Korea Neoantigens Market, By Line of Therapy |
6.3.1 Overview and Analysis |
6.3.2 South Korea Neoantigens Market Revenues & Volume, By First Line, 2021- 2031F |
6.3.3 South Korea Neoantigens Market Revenues & Volume, By Second Line, 2021- 2031F |
6.3.4 South Korea Neoantigens Market Revenues & Volume, By Later Lines, 2021- 2031F |
6.4 South Korea Neoantigens Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 South Korea Neoantigens Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 South Korea Neoantigens Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 South Korea Neoantigens Market Revenues & Volume, By Specialty Centers, 2021- 2031F |
6.4.5 South Korea Neoantigens Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Neoantigens Market Import-Export Trade Statistics |
7.1 South Korea Neoantigens Market Export to Major Countries |
7.2 South Korea Neoantigens Market Imports from Major Countries |
8 South Korea Neoantigens Market Key Performance Indicators |
8.1 Patient response rates to neoantigen therapies |
8.2 Number of clinical trials conducted for neoantigen-based treatments in South Korea |
8.3 Rate of adoption of personalized medicine in the oncology field |
9 South Korea Neoantigens Market - Opportunity Assessment |
9.1 South Korea Neoantigens Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 South Korea Neoantigens Market Opportunity Assessment, By Therapeutic Specialty, 2021 & 2031F |
9.3 South Korea Neoantigens Market Opportunity Assessment, By Line of Therapy, 2021 & 2031F |
9.4 South Korea Neoantigens Market Opportunity Assessment, By End users, 2021 & 2031F |
10 South Korea Neoantigens Market - Competitive Landscape |
10.1 South Korea Neoantigens Market Revenue Share, By Companies, 2024 |
10.2 South Korea Neoantigens Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here